Single Daily Dosing of Wellbutrin SR
Single daily dosing of Wellbutrin SR is not recommended according to the FDA drug label, which specifies a twice-daily dosing regimen for the sustained-release (SR) formulation. 1
Proper Dosing of Bupropion Formulations
Wellbutrin SR (Sustained-Release)
- Recommended dosing: 150 mg twice daily 1
- Maximum daily dose: 300 mg (divided into two doses) 1
- Doses should be separated by at least 8 hours to minimize seizure risk 1
Alternative Formulations
- Immediate-release (IR): Three times daily dosing 2
- Extended-release (XL): Once daily dosing in the morning 1
- XL formulation is specifically designed for once-daily administration
- Starting dose: 150 mg once daily in the morning
- Target dose: 300 mg once daily in the morning
Risks of Inappropriate Dosing
Seizure Risk
- Bupropion carries a dose-dependent seizure risk of approximately 0.1% 3
- Risk increases when exceeding recommended doses or with improper dosing intervals 1
- Gradual dose increases are essential to minimize seizure risk 1
Adherence Concerns
- Research shows adherence decreases with multiple daily doses 4:
- 15% nonadherence with once-daily dosing
- 37% nonadherence with twice-daily dosing
- 65% nonadherence with thrice-daily dosing
Clinical Considerations
Efficacy
- Clinical studies have specifically evaluated the SR formulation at twice-daily dosing 5
- While one older study suggested once-daily SR might be effective 5, this is not supported by the FDA-approved labeling 1
Pharmacokinetics
- SR formulation is designed for twice-daily administration to maintain therapeutic blood levels 1
- Single daily dosing of SR formulation may result in:
- Suboptimal blood levels in latter part of day
- Increased peak concentrations that could raise side effect risk
Side Effects
- Common side effects of bupropion SR include insomnia, headache, dry mouth, and anxiety 6
- Insomnia risk may increase if the second dose is taken too late in the day 3
- The American College of Physicians recommends taking the second daily dose before 3 p.m. to minimize insomnia risk 3
Recommendations for Patients Seeking Once-Daily Dosing
If once-daily dosing is strongly preferred by a patient:
- Consider switching to bupropion XL (extended-release) formulation which is specifically designed and FDA-approved for once-daily dosing 1
- When switching from SR to XL, maintain the same total daily dose when possible 1
- Administer bupropion XL in the morning to minimize insomnia risk 1
Conclusion
For patients requiring bupropion therapy who prefer once-daily dosing, the extended-release (XL) formulation should be used rather than attempting once-daily dosing with the SR formulation. This approach aligns with FDA recommendations and optimizes both efficacy and safety.